MMP2 and sarcoma: In the chicken chorioallantoic membrane assay, reduced new vessel formation. In mice decreases the weight of sarcoma-180 cells-induced tumor in a dose-dependent manner. Also decreased Tissue Factor (TF) expression without affecting the activities of MMP-2 and−9.